未登录

M

Min Zheng

fujian medical university

H指数:23

被引数:1,797

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ChaC1-based drug screenings identify a synergistic lethal effect of auranofin and proteasome inhibitors in hepatocellular carcinoma cells

基于ChaC1的药物筛选鉴定出奥拉帕利和蛋白酶体抑制剂在肝细胞癌细胞中的协同致死效应

Cell Death Discovery

IF7

2025-11-170

OAAI

BRD4 regulates PAI-1 expression in tumor-associated macrophages to drive chemoresistance in colorectal cancer

BRD4通过调节肿瘤相关巨噬细胞中PAI-1的表达来驱动结直肠癌的化疗耐药性。

IF7.3

2025-05-280

PRE

Corrigendum to Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/ E-cadherin pathway [Cancer Lett. 444 (2019) 82-93]

IF10.1

2024-11-010

PRE

Ubiquitin-Specific Protease USP6 Regulates the Stability of the c-Jun Protein

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-0325

OAAI

Positive H. pylori status predicts better prognosis of non-cardiac gastric cancer patients: results from cohort study and meta-analysis

IF3.4

2022-02-0815

OAAI

Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma

IF10.1

2022-01-0127

PRE

Cobalt induces neurodegenerative damages through Pin1 inactivation in mice and human neuroglioma cells

JOURNAL OF HAZARDOUS MATERIALS

IF11.3

2021-10-0133

PREAI

Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2021-05-01108

OAAI

Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1-mediated EMT

Regorafenib通过靶向ID1-mediated EMT抑制肝细胞癌的迁移，侵袭和血管生成拟态

MOLECULAR CARCINOGENESIS

IF3.2

2021-01-1117

PREAI

PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers

MOLECULAR CANCER THERAPEUTICS

IF5.5

2020-03-0225

OAAI

Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways

MOLECULAR CARCINOGENESIS

IF3.2

2019-04-2632

OAAI

Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway

IF10.1

2019-03-0147

OAAI

CDK7 activated beta-catenin/TCF signaling in hepatocellular carcinoma

EXPERIMENTAL CELL RESEARCH

IF3.5

2018-09-0111

PREAI

GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma

MOLECULAR MEDICINE REPORTS

IF3.5

2018-01-1510

OAAI

MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways

SCIENTIFIC REPORTS

IF3.9

2017-04-0649

OAAI

Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways

SCIENTIFIC REPORTS

IF3.9

2017-03-0640

OAAI

Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

IF3.3

2015-07-0151

PREAI

The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation

IF6.9

2015-04-0182

OAAI

Tumor Necrosis Factor Alpha and Interleukin-6 Facilitate Corneal Lymphangiogenesis in Response to Herpes Simplex Virus 1 Infection

JOURNAL OF VIROLOGY

IF3.8

2014-12-1553

OAAI

Side-effects of resveratrol in HepG2 cells: Reduced pten and increased bcl-xl mRNA expression

白藜芦醇在HepG2细胞中的副作用: pten减少和bcl-xl mRNA表达增加

MOLECULAR MEDICINE REPORTS

IF3.5

2012-09-1212

OAAI